Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Mirza I. Rahman"'
Publikováno v:
Principles and Practice of Pharmaceutical Medicine. :301-314
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b79437504f88c05ffd152e0a7e4a7be7
https://doi.org/10.1002/9781444325263.ch25
https://doi.org/10.1002/9781444325263.ch25
Autor:
Mirza I. Rahman, Robbert P. van Manen
Publikováno v:
Principles and Practice of Pharmaceutical Medicine. :587-600
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2322ff7caba6dc87a3070a966bb79e29
https://doi.org/10.1002/9781444325263.ch44
https://doi.org/10.1002/9781444325263.ch44
Autor:
Mirza I. Rahman, David Hendricks, Gary R. Lichtenstein, Jenna Kelly, Heidi C. Waters, Elaine L. Zanutto, Susan McDonald
Publikováno v:
The Patient: Patient-Centered Outcomes Research. 3:113-123
Background: Patient preference has been recognized as being of increasing importance when choosing a drug therapy for chronic conditions for which there are no cures and for which long-term treatment is needed. Objective: To quantify treatment prefer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5b0812a8a5469c4fd171b374cf74551
https://doi.org/10.2165/11314880-000000000-00000
https://doi.org/10.2165/11314880-000000000-00000
Autor:
Gary R. Lichtenstein, Heidi C. Waters, Jenna Kelly, Susan S. McDonald, Elaine L. Zanutto, David Hendricks, Mirza I. Rahman
Publikováno v:
The Patient: Patient-Centered Outcomes Research. 3(2):113-123
Background: Patient preference has been recognized as being of increasing importance when choosing a drug therapy for chronic conditions for which there are no cures and for which long-term treatment is needed. Objective: To quantify treatment prefer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______645::db1efdfc6d17ab546f073af52237dbb0
http://thepatient.adisonline.com/pt/re/ptt/pdfhandler.01312067-201003020-00005.pdf
http://thepatient.adisonline.com/pt/re/ptt/pdfhandler.01312067-201003020-00005.pdf
Publikováno v:
Clinical Therapeutics. 30:1375-1384
Anti-tumor necrosis factor (TNF) biologic agents are effective in treating rheumatoid arthritis (RA). Information on patient persistence with biologic anti-TNF therapies is limited, and the effects of persistence on the costs of therapy are unknown.T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f2aa013d09e6b7f91d8081f58c5be1a
https://doi.org/10.1016/s0149-2918(08)80063-x
https://doi.org/10.1016/s0149-2918(08)80063-x
Autor:
Marius E Chagoury, Mirza I Rahman
Publikováno v:
Family Practice. 11:96-101
If the results of LIMIT-2, the two meta-analyses reviewed and the cumulative meta-analysis by Lau et al. are viewed in aggregate, there can be very little doubt regarding the beneficial effects of i.v. magnesium on mortality in suspected acute MI. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5711c7abcd365526fbb0a297d68d2a73
https://doi.org/10.1093/fampra/11.1.96
https://doi.org/10.1093/fampra/11.1.96
Autor:
Mirza I Rahman, Marius E Chagoury
Publikováno v:
Family Practice. 11:333-339
Of the five modalities currently used to screen for colorectal cancer, the DRE is the least useful as a solitary screening tool. Also, while FOBT is widely used, its high false positive rate and uncertain cost benefit ratio make it less than ideal as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44dd1a80b424850c28597bdad9288c3d
https://doi.org/10.1093/fampra/11.3.333
https://doi.org/10.1093/fampra/11.3.333
Publikováno v:
Inflammatory bowel diseases. 14(12)
Background: Fistulas are a common complication of Crohn's disease (CD) and are difficult to treat effectively. This study aimed to assess the effects of fistula on annual costs of healthcare and resource utilization for patients with CD. Methods: A r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75e62d2502572fc3507feb6da2fe43ea
https://pubmed.ncbi.nlm.nih.gov/18618630
https://pubmed.ncbi.nlm.nih.gov/18618630
Autor:
Juvairiya Pulicharam, Ron Ferrer, Bijan Nejadnik, Elton Teng, Rhadjena P. Hilliard, Mirza I. Rahman, Heidi C. Waters
Publikováno v:
Digestive diseases and sciences. 54(12)
Objective To evaluate the healthcare costs and resource utilization associated with pediatric Crohn’s disease (PCD) from a payer perspective. Methods A retrospective analysis was conducted using claims from 1 January 2003 through 31 December 2006 f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::547b09c348b1cc2cc5ba935865150646
https://pubmed.ncbi.nlm.nih.gov/19130225
https://pubmed.ncbi.nlm.nih.gov/19130225
